2009
DOI: 10.1001/jama.2009.1308
|View full text |Cite|
|
Sign up to set email alerts
|

Evaluating Dopamine Reward Pathway in ADHD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

25
399
4
11

Year Published

2010
2010
2019
2019

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 572 publications
(456 citation statements)
references
References 55 publications
(54 reference statements)
25
399
4
11
Order By: Relevance
“…The training also includes delivery of rewards for correct performance, which likely acts on the basal ganglia, although both training and placebo groups would have received rewards. Stimulant treatment, such as methylphenidate, is known to act directly on brain regions associated with disrupted dopamine reward pathways in ADHD [62,63] and may be responsible for the global effects seen with stimulant treatment in ADHD. Understanding and comparing the effects of treatments that directly manipulate dopaminergic functioning via pharmacological approaches versus delivering of conditioned rewards as feedback within the training system have not been conducted.…”
Section: Discussionmentioning
confidence: 99%
“…The training also includes delivery of rewards for correct performance, which likely acts on the basal ganglia, although both training and placebo groups would have received rewards. Stimulant treatment, such as methylphenidate, is known to act directly on brain regions associated with disrupted dopamine reward pathways in ADHD [62,63] and may be responsible for the global effects seen with stimulant treatment in ADHD. Understanding and comparing the effects of treatments that directly manipulate dopaminergic functioning via pharmacological approaches versus delivering of conditioned rewards as feedback within the training system have not been conducted.…”
Section: Discussionmentioning
confidence: 99%
“…Human brain imaging and animal studies have strongly suggested that a hypofunctional dopamine system underlies the core symptoms of attention deficit/hyperactivity disorder (ADHD) [15][16][17][18] . The low-dopamine theory explains why low levels of stimulant drugs mildly increase brain dopamine levels but paradoxically reduce the hyperactivity in human ADHD.…”
Section: Selective Activation Of Midbrain Dopaminergic Neuronsmentioning
confidence: 99%
“…For example, both increases and decreases have been reported for D 2 /D 3 receptor availability and for dopamine transporter (DAT) binding in ADHD patients vs controls (Lou et al, 2004;Spencer et al, 2005;Spencer et al, 2013;Volkow et al, 2007a;Volkow et al, 2009). Only one study has examined DA release in untreated ADHD (Volkow et al, 2007b).…”
Section: Introductionmentioning
confidence: 99%